Evaluation of mucociliary clearance‘s (MCC) condition in patients with COPD. Influence of tiotropium bromide (TB) on MCC Source: Annual Congress 2007 - Treatment of COPD Year: 2007
Influence of tiotropium bromide (TB) on mucociliary clearance (MCC) in patients with COPD Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009
Influence of tiotropium bromide (TB) and carbocysteine (C) on mucociliary clearance (MCC) in patients with COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Evaluation of bronchodilator response to single dose tiotropium bromide Source: Eur Respir J 2004; 24: Suppl. 48, 504s Year: 2004
Tiotropium bromide: Efficacy and safety in complex treatment of COPD Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
Effects of twice-daily aclidinium bromide in COPD patients: A long-term extension of ACCORD-COPD I Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Effect of salmeterol/fluticasone propionate versus tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study Source: Eur Respir J 2007; 30: Suppl. 51, 34s Year: 2007
Monitoring of nasal permeability during the treatmrnt of patients with overlap syndrome with combined broncholytic drug (ipratropium bromide + salbutamol) Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001
Bronchodilator/bronchoprotective effects of aclidinium bromide, a novel long-acting anticholinergic: a phase I study Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
The effect of tiotropium bromide in a stable cohort of COPD patients in Portugal Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005
Efficacy and safety of extrafine glycopyrronium bromide (GB) in uncontrolled asthmatic patients Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
Reversibility effects of ipratropium bromide and terbutalin sulphate in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 72s Year: 2001
Bronchodilator effects of aclidinium bromide, a novel long-acting anticholinergic, in COPD patients: a phase II study Source: Annual Congress 2007 - New drugs for COPD Year: 2007
Salbutamol or ipratropium bromide: does gender and age influence the response to drugs? Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021
Comparative study of one-year treatment with salmeterol along, and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructi e pulmonary diseases (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Basic ways of tiotropium bromide‘s (TB) influence on mucociliary clearance (MCC) Source: Annual Congress 2010 - COPD: management Year: 2010
Inhibiting effects of tiotropium bromide on neocollagenesis during 6 month treatment Source: Annual Congress 2011 - COPD management Year: 2011
Sleep architecture in COPD patients during salmeterol versus ipratropium bromide treatment Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Tiotropium bromide (TIO) reduces hospitalizations in patients with COPD who had been refractory to treatment with combined inhaled corticosteroid/long acting beta agonist (ICS/LABA) Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005
The efficacy of long-acting anticholinergic agent, tiotropium bromide on dynamic hyperinflation in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006